What is the recommended treatment for pyelonephritis due to Enterococcus faecalis in an adult without beta‑lactam allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pyelonephritis Caused by Enterococcus faecalis

For pyelonephritis caused by Enterococcus faecalis in adults without beta-lactam allergy, ampicillin monotherapy (2g IV every 4-6 hours) is the first-line treatment, with a duration of 10-14 days. 1, 2

Primary Treatment Approach

  • Ampicillin remains the drug of choice for E. faecalis infections when the organism is susceptible (penicillin MIC ≤8 mg/L), with high-dose regimens of 18-30g IV daily in divided doses recommended to achieve sufficient therapeutic concentrations. 2

  • For pyelonephritis specifically, ampicillin 2g IV every 4-6 hours for 10-14 days is the standard regimen, as beta-lactam agents require this extended duration compared to other antimicrobials. 1

  • If the patient can tolerate oral therapy and the organism is confirmed susceptible, amoxicillin 500mg PO every 8 hours can be used to complete the treatment course. 2

Alternative Regimens When Ampicillin Alone is Insufficient

  • For severe pyelonephritis requiring hospitalization or if bacteremia is suspected, consider adding gentamicin (if aminoglycoside-susceptible) to ampicillin for synergistic bactericidal activity, though this is more commonly reserved for endocarditis than uncomplicated pyelonephritis. 1, 2

  • If the isolate demonstrates high-level aminoglycoside resistance (HLAR), the double beta-lactam combination of ampicillin 2g IV every 4 hours PLUS ceftriaxone 2g IV every 12 hours provides excellent bactericidal activity with lower nephrotoxicity risk compared to aminoglycoside-containing regimens. 3, 4

Important Clinical Considerations

  • E. faecalis is generally ampicillin-susceptible (only ~3% are multidrug-resistant), making it much more amenable to treatment than E. faecium. 2

  • Always obtain susceptibility testing to confirm ampicillin susceptibility and guide definitive therapy, as empiric coverage should be tailored once culture results are available. 1

  • Avoid cephalosporins as monotherapy (except in double beta-lactam regimens with ampicillin), as most cephalosporins have poor activity against enterococci. 2

  • Nitrofurantoin should NOT be used for pyelonephritis despite its excellent activity against E. faecalis in cystitis, as it achieves inadequate tissue concentrations for upper urinary tract infections. 2

When to Consider Vancomycin

  • Vancomycin 30 mg/kg per 24h IV in 2 divided doses should be reserved for patients with documented beta-lactam allergy or ampicillin-resistant strains, though resistance rates remain low in E. faecalis. 2

Duration and Monitoring

  • 10-14 days of therapy is required when using beta-lactam agents for pyelonephritis, which is longer than the 5-7 day courses used for fluoroquinolones. 1

  • Monitor renal function if aminoglycosides are added, as nephrotoxicity occurs in approximately 23% of patients receiving ampicillin-gentamicin combinations. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Effective Antibiotics for Enterococcus faecalis Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Double Beta-Lactam Therapy in Endocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.